๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

A Mathematical Model for the Effects of HER2 Overexpression on Cell Proliferation in Breast Cancer

โœ Scribed by Amina Eladdadi; David Isaacson

Book ID
107385981
Publisher
Springer
Year
2008
Tongue
English
Weight
550 KB
Volume
70
Category
Article
ISSN
1522-9602

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Targeting endothelin A receptor enhances
Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells
โœ Jeanett Fischgrรคbe; Martin Gรถtte; Katharina Michels; Ludwig Kiesel; Pia Wรผlfing ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 600 KB

Human epidermal growth factor receptor 2 (HER2) is frequently overexpressed in human breast cancers. It is known to drive tumor growth and progression and represents a prominent target in breast cancer therapy. The endothelin (ET) system, in particular ET-1 and its receptor ET A R, is of major relev

Genistein sensitizes inhibitory effect o
Genistein sensitizes inhibitory effect of tamoxifen on the growth of estrogen receptor-positive and HER2-overexpressing human breast cancer cells
โœ Zhiming Mai; George L. Blackburn; Jin-Rong Zhou ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 267 KB

## Abstract Although tamoxifen (TAM) is used for the frontโ€line treatment and prevention of estrogen receptorโ€positive (ER+) breast tumors, nearly 40% of estrogenโ€dependent breast tumors do not respond to TAM treatment. Moreover, the positive response is usually of short duration, and most tumors e

Identification of a small peptide that i
Identification of a small peptide that inhibits the phosphorylation of ErbB2 and proliferation of ErbB2 overexpressing breast cancer cells
โœ Stephanie C. Pero; Girja S. Shukla; Amy L. Armstrong; Daniel Peterson; Susan P. ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 772 KB

## Abstract ErbB2 is overexpressed in approximately 30% of breast cancer patients with a correlation to poor prognosis. ErbB2 has been identified as a useful receptor for molecular targeting. A cyclic 20 amino acid phage display random peptide library was constructed using the fUSE5 gene III system